Characteristics of patients who achieved a CR and CRp
| Characteristic . | CR patients . | CRp patients . | Total patients . |
|---|---|---|---|
| No. patients | 9 | 2 | 11 |
| Median age (range), y | 70 (28-79) | 60.5 (60-61) | 67 (28-79) |
| Relapsed/refractory status, no. patients | 6/3 | 1/1 | 7/4 |
| Karyotype, no. patients | |||
| Normal | 4 | 1 | 5 |
| Abnormal | 4 | 1 | 5 |
| Chromosome 5, 7, or 11 abnormality | 1 | 1 | 2 |
| Other | 3 | 0 | 3 |
| Unknown | 1 | 0 | 1 |
| Median time to response, days | 58 | 68 | 58 |
| Median duration of response, days (95% CI) | 78 (40, 107) | NAp (92+, 130+) | 78 (40, NAp) |
| Characteristic . | CR patients . | CRp patients . | Total patients . |
|---|---|---|---|
| No. patients | 9 | 2 | 11 |
| Median age (range), y | 70 (28-79) | 60.5 (60-61) | 67 (28-79) |
| Relapsed/refractory status, no. patients | 6/3 | 1/1 | 7/4 |
| Karyotype, no. patients | |||
| Normal | 4 | 1 | 5 |
| Abnormal | 4 | 1 | 5 |
| Chromosome 5, 7, or 11 abnormality | 1 | 1 | 2 |
| Other | 3 | 0 | 3 |
| Unknown | 1 | 0 | 1 |
| Median time to response, days | 58 | 68 | 58 |
| Median duration of response, days (95% CI) | 78 (40, 107) | NAp (92+, 130+) | 78 (40, NAp) |